GleamWall
中文EN

CYAN CYANOTECH CORP

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 768408 · Fiscal year ends 03/31

Financial factors as of 2025-09-30 (2025Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.5%
TTM net income YoY67.4%
TTM EPS YoY69.9%
Revenue 3-yr CAGR-5.0%
Net income 3-yr CAGR—

Margins

Gross margin32.0%
Operating margin-4.2%
Net margin-7.0%
FCF margin-5.7%
EBITDA margin1.5%

Returns

ROE-20.0%
ROA-7.4%
ROIC (approx.)-5.3%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets66.4%
Debt / equity1.04x
Current ratio1.00x
Interest coverage-1.48x

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2025Q22025-09-302025Q12025-06-302025Q4*2025-03-312024Q32024-12-312024Q22024-09-302024Q12024-06-302024Q4*2024-03-312023Q32023-12-31
Income statement
Revenue$6.98M$5.82M$6.30M$6.17M$5.84M$5.90M$5.97M$5.58M
Cost of revenue$4.58M$4.05M$4.56M$3.99M$4.37M$4.42M$5.29M$3.93M
Gross profit$2.39M$1.77M$1.74M$2.18M$1.48M$1.48M$675,000$1.65M
R&D expense$78,000$74,000$101,000$127,000$137,000$84,000$159,000$163,000
SG&A expense$996,000$1.30M$873,000$1.01M$1.24M$1.27M$1.08M$947,000
Operating income$190,000-$753,000-$442,000-$50,000-$975,000-$1.04M-$1.90M-$848,000
Interest expense$189,000$173,000$177,000$174,000$175,000$161,000$173,000$172,000
Pretax income$1,000-$926,000-$619,000-$224,000-$1.15M-$1.20M-$2.08M-$1.02M
Income tax$0$0$8,000$0$0$0$5,000$0
Net income$1,000-$926,000-$627,000-$224,000-$1.15M-$1.20M-$2.08M-$1.02M
EBITDA$536,000-$391,000-$84,000$320,000-$602,000-$663,000-$1.52M-$453,000
EPS (basic)0.00-0.13—-0.03-0.16-0.17—-0.16
EPS (diluted)0.00———-0.16-0.17—-0.16
Weighted avg. shares (diluted)7.29M———7.00M6.95M—6.55M
Balance sheet
Cash & equivalents$649,000$383,000$257,000$359,000$780,000$720,000$707,000$661,000
Receivables$2.35M$1.56M$1.95M$1.91M$1.59M$2.14M$2.10M$2.04M
Inventory$8.38M$8.11M$7.79M$7.75M$7.18M$6.96M$7.31M$9.12M
Current assets$11.93M$10.52M$10.54M$10.55M$10.12M$10.37M$10.59M$12.29M
PP&E, net$8.35M$8.59M$8.93M$9.26M$9.51M$9.78M$10.11M$10.43M
Total assets$24.03M$23.00M$23.49M$23.96M$23.91M$24.43M$25.11M$27.25M
Current liabilities$11.89M$10.78M$10.24M$9.95M$9.57M$10.16M$8.55M$8.54M
Short-term debt$7.36M$7.13M$6.65M$6.59M$6.02M$6.45M$5.63M$5.81M
Long-term debt$1.00M$1.00M$1.00M$1.00M$1.00M$0$1.00M$1.00M
Total debt$8.36M$8.13M$7.65M$7.59M$7.02M$6.45M$6.63M$6.81M
Total liabilities$15.96M$14.99M$14.61M$14.46M$14.22M$13.77M$13.30M$13.42M
Shareholders' equity$8.06M$8.00M$8.88M$9.50M$9.69M$10.66M$11.81M$13.83M
Net debt$7.71M$7.75M$7.39M$7.24M$6.24M$5.73M$5.92M$6.15M
Shares outstanding7.39M7.23M7.20M7.16M7.14M6.95M6.95M6.89M
Cash flow statement
Operating cash flow$108,000-$328,000-$57,000-$935,000-$444,000$243,000$307,000-$1.00M
Capital expenditure$64,000$22,000$84,000$58,000$58,000$47,000$58,000$37,000
Free cash flow$44,000-$350,000-$141,000-$993,000-$502,000$196,000$249,000-$1.04M
Investing cash flow-$64,000-$22,000-$84,000-$58,000-$58,000-$47,000-$58,000-$37,000
Financing cash flow$222,000$476,000$39,000$572,000$562,000-$183,000-$203,000$462,000
Depreciation & amortization$346,000$362,000$358,000$370,000$373,000$378,000$383,000$395,000
Stock-based compensation$25,000$49,000$20,000$33,000$146,000$48,000$83,000$54,000

Free plan shows the latest 8 periods; Pro shows all 62 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.